Acute Myeloid Leukemia Panel - Disclosures
|
Panel Member
|
Jessica Altman MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Rita Assi MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Ajibola Awotiwon MBBS, MSc |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Kimo Bachiashvili MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Vijaya Raj Bhatt MBBS, MS |
|
Grant/Research Support
|
| AbbVie, Inc. | Actinium Pharmaceutical | Chimerix | Cynata Therapeutics | Incyte Corporation | Jazz Pharmaceuticals Inc. | MEI Pharma Inc. | National Marrow Donor Program | Pfizer Inc. | sanofi-aventis U.S. |
|
Date Completed
|
07/29/2024 |
|
Panel Member
|
Marian Birkeland PhD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Nicole Blankenhorn |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Amir Fathi MD |
|
Grant/Research Support
|
| AbbVie, Inc. | Bristol Myers Squibb | Servier |
|
Date Completed
|
07/29/2024 |
|
Panel Member
|
Meghan Fay BSN, RN, OCN |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Kateryna Fedorov MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Tanya Fischer MEd, MLIS |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
James Foran MD |
|
Grant/Research Support
|
| Astellas Pharma US, Inc. | Celgene Corporation | Chordia | DISC | Kura Oncology, Inc. | Novartis Pharmaceuticals Corporation | sellas |
|
Date Completed
|
03/14/2025 |
|
Panel Member
|
Ivana Gojo MD |
|
Grant/Research Support
|
| Amgen Inc. | Gilead Sciences, Inc. | Incyte Corporation | Kura Oncology, Inc. | Merck & Co., Inc. |
|
Date Completed
|
07/14/2024 |
|
Panel Member
|
Aaron Goldberg MD, PhD |
|
Grant/Research Support
|
| AbbVie, Inc. | Kura Oncology, Inc. |
|
Date Completed
|
05/02/2025 |
|
Panel Member
|
Kristina Gregory MSN, RN |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Aric Hall MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Evelyn Handel PharmD, BCOP, BCPS |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Erin Hesler |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Brian Jonas MD, PhD |
|
Grant/Research Support
|
| AbbVie, Inc. | Amgen Inc. | Aptose | AROG | Biomea | Bristol Myers Squibb | Celgene Corporation | Forma | Forty Seven, Inc. | Genentech, Inc. | Gilead Sciences, Inc. | GlycoMimetics, Inc. | Hanmi | Immune-Onc | Jazz Pharmaceuticals Inc. | Kymera | Loxo | Pfizer Inc. | Pharmacyclics | Treadwell |
|
Date Completed
|
07/21/2024 |
|
Panel Member
|
Matthew R Levine MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Daniel Lui PharmD, BCPPS |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
James Mangan MD, PhD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Gabriel Mannis MD |
|
Grant/Research Support
|
| Aptose | Astex Pharmaceuticals | Bristol Myers Squibb | Gilead Sciences, Inc. | GlycoMimetics, Inc. | ImmuneOnc | ImmunoGen, Inc. | Jazz Pharmaceuticals Inc. | Syndax |
|
Date Completed
|
03/17/2025 |
|
Panel Member
|
Guido Marcucci MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Alice Mims MD, MS |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Kelsey Moriarty MS, CGC |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Moaath Mustafa Ali MD, MPH |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Jadee Neff MD, PhD |
|
Product/Speakers Bureau
|
| Recordati/EUSA |
|
Date Completed
|
08/19/2024 |
|
Panel Member
|
Reza Nejati MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Rebecca Olin MD, MSCE |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Anand Patel MD |
|
Grant/Research Support
|
| Incyte Corporation | Kronos Bio | Pfizer Inc. | Servier | Sumitomo |
|
Date Completed
|
01/14/2025 |
|
Panel Member
|
Mary-Elizabeth Percival MD, MS |
|
Grant/Research Support
|
| AbbVie, Inc. | Ascentage | Astex Pharmaceuticals | Biosight | Celgene Corporation | GlycoMimetics, Inc. | ImmunoGen, Inc. | Pfizer Inc. | VinceRx |
|
Date Completed
|
07/29/2024 |
|
Panel Member
|
Alexander Perl MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Kristen Pettit MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Daniel Pollyea MD, MS |
|
Grant/Research Support
|
| AbbVie, Inc. | Bristol Myers Squibb |
|
Date Completed
|
06/18/2024 |
|
Panel Member
|
Donna Powell DHSc, CMD, RT(T) |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Dinesh Rao MD, PhD |
|
Product/Speakers Bureau
|
| AbbVie, Inc. |
|
Date Completed
|
07/29/2024 |
|
Panel Member
|
Farhad Ravandi MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Zaker Schwabkey MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Rory Shallis MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Katie Stehman MMS, PA-C |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Richard Stone MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Swapna Thota MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Geoffrey Uy MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Alison Walker MD, MBA, MPH |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Eunice Wang MD |
|
Product/Speakers Bureau
|
| Astellas Pharma US, Inc. | Dava Oncology | Pfizer Inc. |
|
Royalty Income
|
| UpToDate |
|
Date Completed
|
08/25/2024 |
